Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Current Assets:    
Cash $ 2,021 $ 225,379
Escrow fund 79,855
Accounts receivable 86
Deposit on contract 75,000
Prepaid expenses and other current assets 157,500 119,545
Total current assets 159,607 499,779
Other Assets:    
Property and equipment, net 29,279 38,735
Deposit 41,876 44,876
Total Assets 230,762 583,390
Current Liabilities:    
Accounts payable and accrued expenses 296,931 34,450
Demand obligation payable - related party 90,000
Convertible notes payable 713,158
Convertible note payable - related party 100,000
Accrued interest 211,965
Short-term advance - related party 57,400
Total current liabilities 1,469,454 34,450
Long Term Liabilities:    
Derivative liabilities 262,823 4,392,075
Total long term liabilities 262,823 4,392,075
Total liabilities 1,732,277 4,426,525
Commitments and Contingencies
Mezzanine Equity    
Preferred Series A stock, par value $.01 per share, 134,000 shares authorized; 133,334 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively. Stated at redemption value. 1,500,004 1,500,004
Shareholders' Equity/(Deficit):    
Preferred Stock, par value $.01, 10,000,000 shares authorized all series [1] 154 210
Common stock, par value $.001 per share, 500,000,000 shares authorized; 47,269,804 and 44,520,065 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 47,270 44,520
Additional paid-in capital (738,877) (1,518,484)
Accumulated deficit (2,310,066) (3,869,385)
Total shareholders' equity/(deficit) (3,001,519) (5,343,139)
Total Liabilities and Shareholders' Equity/(Deficit) $ 230,762 $ 583,390
[1] Preferred Series A-1 stock, par value $.01 per share, 21,000 shares authorized; 14,923 and 20,371 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively; Preferred Series B stock, par value $.01 per share, 300,000 shares authorized; no shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively; Preferred Series C stock, par value $.01 per share, 502 and 615 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively